16
Participants
Start Date
November 30, 1998
Primary Completion Date
October 31, 2004
Study Completion Date
September 30, 2005
recombinant human thrombopoietin
carboplatin
etoposide
ifosfamide
G-CSF
Princess Margaret Hospital for Children, Perth
Kaplan Cancer Center, New York
Memorial Sloan-Kettering Cancer Center, New York
Herbert Irving Comprehensive Cancer Center, New York
Children's Hospital of Pittsburgh, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
University of Wisconsin Comprehensive Cancer Center, Madison
University of Minnesota Cancer Center, Minneapolis
Mayo Clinic Cancer Center, Rochester
Children's Mercy Hospital - Kansas City, Kansas City
University of Texas - MD Anderson Cancer Center, Houston
Huntsman Cancer Institute, Salt Lake City
Long Beach Memorial Medical Center, Long Beach
Beckman Research Institute, City of Hope, Los Angeles
Children's Hospital of Orange County, Orange
Children's Hospital and Regional Medical Center - Seattle, Seattle
Children's Hospital Los Angeles, Los Angeles
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles
UCSF Cancer Center and Cancer Research Institute, San Francisco
Children's National Medical Center, Washington D.C.
Indiana University Cancer Center, Indianapolis
University of Michigan Comprehensive Cancer Center, Ann Arbor
Children's Hospital Medical Center - Cincinnati, Cincinnati
Vanderbilt Cancer Center, Nashville
National Cancer Institute (NCI)
NIH
Children's Oncology Group
NETWORK